Score Overview
Explore the 2021 public Archive ranking →
Where ImmuCell Corporation has ranked, year by year
Showing 1 year ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- ICCC
1998: 34.0% · 2021: 26.3% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 9.88 | — |
1 Year2025-09-26 | $ 6.03 | 63.85% |
5 Years2021-09-28 | $ 9.38 | 5.33% |
10 Years2016-09-28 | $ 7.98 | 23.81% |
20 Years2006-09-28 | $ 4.89 | 102.04% |
30 Years1996-09-27 | $ 3.13 | 216.16% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 |
|---|---|---|---|---|---|---|
| Price | $ 9.88 | $ 6.03 | $ 9.38 | $ 7.98 | $ 4.89 | $ 3.13 |
| Return | — | 63.85% | 5.33% | 23.81% | 102.04% | 216.16% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 29M | -$ 545.4K | $ 6M |
| 2025 | $ 27M | -$ 1M | $ 3M |
| 2024 | $ 26M | -$ 2M | $ 3M |
| 2023 | $ 17M | -$ 5M | $ 978.74K |
| 2022 | $ 18M | -$ 2M | $ 5M |
| 2021 | $ 19M | -$ 78.29K | $ 10M |
| 2020 | $ 15M | -$ 1M | $ 7M |
| 2019 | $ 13M | -$ 1M | $ 8M |
| 2018 | $ 10M | -$ 2M | $ 2M |
| 2017 | $ 10M | -$ 168K | $ 3M |
| 2016 | $ 9M | $ 508.45K | $ 10M |
| 2015 | $ 10M | $ 1M | $ 6M |
| 2014 | $ 7M | -$ 167.16K | $ 3M |
| 2013 | $ 6M | $ 117.39K | $ 5M |
| 2012 | $ 5M | $ 89.51K | $ 4M |
| 2011 | $ 5M | -$ 409.51K | $ 4M |
| 2010 | $ 4M | -$ 384.68K | $ 4M |
| 2009 | $ 4M | -$ 216.49K | $ 4M |
| 2008 | $ 4M | -$ 468.56K | $ 5M |
| 2007 | $ 6M | $ 662.14K | $ 5M |
| 2006 | $ 4M | $ 647.14K | $ 6M |
| 2005 | $ 4M | $ 707.78K | $ 5M |
| 2004 | $ 3M | $ 143.52K | $ 4M |
| 2003 | $ 3M | $ 411.22K | $ 4M |
| 2002 | $ 6M | $ 886.24K | $ 3M |
| 2001 | $ 6M | $ 420K | $ 1M |
| 2000 | $ 5M | $ 2M | $ 1M |
| 1999 | $ 4M | $ 550.84K | $ 1M |
| 1998 | $ 4M | -$ 100K | $ 1M |
| 1997 | $ 4M | $ 300K | $ 1M |
| 1996 | $ 4M | -$ 100K | $ 1M |
| 1995 | $ 4M | $ 1M | |
| 1994 | $ 4M | -$ 100K | $ 1M |
| 1993 | $ 3M | $ 1M | |
| 1992 | $ 3M | -$ 200K | $ 1M |
| 1991 | $ 2M | -$ 1M | $ 800K |
| 1990 | $ 3M | -$ 600K | $ 900K |
| 1989 | $ 2M | -$ 1M | $ 600K |
ImmuCell Corporation fundamental performance
Between 2020 and 2025, revenue grew from $ 15M to $ 27M and net income went from -$ 1M to -$ 1M. Revenue increased in 3 of those 5 years; net income in 3.
Across ImmuCell Corporation's full reported history, from 1989 to 2025, revenue grew from $ 2M to $ 27M and net income went from -$ 1M to -$ 1M. Revenue increased in 68% of the years measured; net income in 55%.
ImmuCell Corporation currently holds a 20-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Membership
Continue ICCC’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
